PSMA CAR mRNA-LNP

Cat. No.: TDLD-0825-LD51

PSMA CAR mRNA-LNP

PSMA CAR mRNA-LNP is a state-of-the-art messenger RNA (mRNA) lipid nanoparticle (LNP) system, specifically engineered for efficient in vitro and in vivo protein expression. This LNP encapsulates mRNA encoding the Chimeric Antigen Receptor (CAR) targeting Prostate-Specific Membrane Antigen (PSMA), serving as an excellent tool for investigating CAR-T cell therapies against BCMA-positive multiple myeloma, enabling studies on targeted immune interception and tumor microenvironment modulation. Engineered with a proprietary lipid formulation for optimal mRNA encapsulation and delivery, it ensures high translation efficiency. Our LNP ensures uniform particle size, high encapsulation efficiency, stability, and effective delivery. Applications of PSMA CAR mRNA-LNP include evaluating CAR expression on engineered T cells and assessing their cytotoxic activity against PSMA-positive cancer cell lines. Please note that this product is intended for research purposes only.